DiogenX
DiogenX is a regenerative diabetes treatment founded in 2019 by Jean-Pascal Tranié, Benjamin Charles and Patrick Collombat.
2
Funding Rounds
$35.1m
Money raised
Overview
DiogenX is a regenerative diabetes treatment founded in 2019 by Jean-Pascal Tranié, Benjamin Charles and Patrick Collombat.
- Website:
- Business model: B2C
- Headquarters: Marseille
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Je********* Tr***** | - | - | - |
| Be****** Ch***** | - | - | |
| Pa***** Co******* | - | - |
Funding
Funding series
Funding Series Analysis
The company DiogenX has raised a total of $35.1m in funding over 2 rounds.
Key Insights:
- DiogenX May 2023 Series A Funding Round: $30m
- DiogenX Seed round, June 2020: $5.1m
DiogenX May 2023 Series A Funding Round
$30m
DiogenX Seed round, June 2020
$5.1m
Industries
DiogenX is active in the following industries: